<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer -a Mendelian Randomization analysis using data from three large cohort studies</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-05-26">2018 May 26.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Katharina</forename><surname>Nimptsch</surname></persName>
							<email>katharina.nimptsch@mdc-berlin.de.</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Molecular Epidemiology Research Group</orgName>
								<orgName type="department" key="dep2">Max Delbrück Center for Molecular Medicine (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mingyang</forename><surname>Song</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Division of Gastroenterology</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Clinical and Translational Epidemiology Unit</orgName>
								<orgName type="institution" key="instit1">Massachusetts General Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Krasimira</forename><surname>Aleksandrova</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="laboratory">Nutrition, Immunity and Metabolism Start-up Lab</orgName>
								<orgName type="institution" key="instit1">German Institute of Human Nutrition (DIfE)</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michail</forename><surname>Katsoulis</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution" key="instit1">Farr Institute of Health Informatics Research at London</orgName>
								<orgName type="institution" key="instit2">UCL</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heinz</forename><surname>Freisling</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mazda</forename><surname>Jenab</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><forename type="middle">J</forename><surname>Gunter</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Konstantinos</forename><forename type="middle">K</forename><surname>Tsilidis</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Department of Hygiene and Epidemiology</orgName>
								<orgName type="institution">University of Ioannina School of Medicine</orgName>
								<address>
									<settlement>Ioannina</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elisabete</forename><surname>Weiderpass</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Community Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution" key="instit1">University of Tromsø</orgName>
								<orgName type="institution" key="instit2">The Arctic University of Norway</orgName>
								<address>
									<settlement>Tromsø</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">Department of Research</orgName>
								<orgName type="institution">Cancer Registry of Norway</orgName>
								<address>
									<settlement>Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
							<affiliation key="aff14">
								<orgName type="department">Department of Medical</orgName>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Samfundet Folkhälsan</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bas</forename><surname>Bueno-De-Mesquita</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">Department for Determinants of Chronic Diseases (DCD)</orgName>
								<orgName type="institution">National Institute for Public Health and the Environment (RIVM)</orgName>
								<address>
									<settlement>Bilthoven</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Department of Social &amp; Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Malaya</orgName>
								<address>
									<settlement>Kuala Lumpur</settlement>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dawn</forename><forename type="middle">Q</forename><surname>Chong</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Gastroenterology</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Clinical and Translational Epidemiology Unit</orgName>
								<orgName type="institution" key="instit1">Massachusetts General Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Division of Medical Oncology</orgName>
								<orgName type="institution">National Cancer Centre Singapore</orgName>
								<address>
									<country key="SG">Singapore</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Majken</forename><forename type="middle">K</forename><surname>Jensen</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chunsen</forename><surname>Wu</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Section for Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="department">Department of Public Health</orgName>
								<orgName type="institution">Aarhus University</orgName>
								<address>
									<settlement>Aarhus</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff24">
								<orgName type="department">Institute of Clinical Research</orgName>
								<orgName type="institution">University of Southern</orgName>
								<address>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="institution">Odense University Hospital</orgName>
								<address>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kim</forename><surname>Overvad</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Section for Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="department">Department of Public Health</orgName>
								<orgName type="institution">Aarhus University</orgName>
								<address>
									<settlement>Aarhus</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tilman</forename><surname>Kühn</surname></persName>
							<affiliation key="aff26">
								<orgName type="department">Division of Cancer Epidemiology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Myrto</forename><surname>Barrdahl</surname></persName>
							<affiliation key="aff26">
								<orgName type="department">Division of Cancer Epidemiology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Olle</forename><surname>Melander</surname></persName>
							<affiliation key="aff27">
								<orgName type="department">Department of Clinical Sciences Lund</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<settlement>Malmö</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Jirström</surname></persName>
							<affiliation key="aff27">
								<orgName type="department">Department of Clinical Sciences Lund</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<settlement>Malmö</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><forename type="middle">H</forename><surname>Peeters</surname></persName>
							<affiliation key="aff28">
								<orgName type="department" key="dep1">Dept of Epidemiology</orgName>
								<orgName type="department" key="dep2">Julius Center for Health Sciences and Primary Care</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff29">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution" key="instit1">MRC-PHE Centre for Environment and Health</orgName>
								<orgName type="institution" key="instit2">Imperial College</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sabina</forename><surname>Sieri</surname></persName>
							<affiliation key="aff30">
								<orgName type="laboratory">Epidemiology and Prevention Unit Fondazione IRCCS</orgName>
								<orgName type="institution">Istituto Nazionale dei Tumori</orgName>
								<address>
									<settlement>Milano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Salvatore</forename><surname>Panico</surname></persName>
							<affiliation key="aff31">
								<orgName type="department">Dipartimento di Medicina Clinica e Chirurgia</orgName>
								<orgName type="institution">Federico II University</orgName>
								<address>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Amanda</forename><forename type="middle">J</forename><surname>Cross</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elio</forename><surname>Riboli</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">The School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bethany</forename><surname>Van Guelpen</surname></persName>
							<affiliation key="aff32">
								<orgName type="department">Department of Radiation Sciences, Oncology</orgName>
								<orgName type="institution">Umeå University</orgName>
								<address>
									<settlement>Umeå</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robin</forename><surname>Myte</surname></persName>
							<affiliation key="aff32">
								<orgName type="department">Department of Radiation Sciences, Oncology</orgName>
								<orgName type="institution">Umeå University</orgName>
								<address>
									<settlement>Umeå</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">José</forename><forename type="middle">María</forename><surname>Huerta</surname></persName>
							<affiliation key="aff33">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">Murcia Regional Health Council</orgName>
								<orgName type="institution" key="instit2">IMIB-Arrixaca</orgName>
								<address>
									<settlement>Murcia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff34">
								<orgName type="institution">CIBER Epidemiología y Salud Pública (CIBERESP)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miguel</forename><surname>Rodriguez-Barranco</surname></persName>
							<affiliation key="aff34">
								<orgName type="institution">CIBER Epidemiología y Salud Pública (CIBERESP)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff35">
								<orgName type="institution">Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">José</forename><surname>Ramón Quirós</surname></persName>
							<affiliation key="aff36">
								<orgName type="institution">Public Health Directorate</orgName>
								<address>
									<settlement>Asturias</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miren</forename><surname>Dorronsoro</surname></persName>
							<affiliation key="aff37">
								<orgName type="institution" key="instit1">Public Health Direction and Biodonostia Research Institute-Ciberesp</orgName>
								<orgName type="institution" key="instit2">Basque Regional Health Department</orgName>
								<address>
									<settlement>San Sebastian</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>Tjønneland</surname></persName>
							<affiliation key="aff38">
								<orgName type="department">Danish Cancer Society Research Center</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><surname>Olsen</surname></persName>
							<affiliation key="aff38">
								<orgName type="department">Danish Cancer Society Research Center</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ruth</forename><surname>Travis</surname></persName>
							<affiliation key="aff39">
								<orgName type="department">Department of Population Health</orgName>
								<orgName type="laboratory">Cancer Epidemiology Unit</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Nuffield, Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marie-Christine</forename><surname>Boutron-Ruault</surname></persName>
							<affiliation key="aff40">
								<orgName type="institution" key="instit1">Université Paris-Saclay</orgName>
								<orgName type="institution" key="instit2">Université Paris-Sud</orgName>
								<orgName type="institution" key="instit3">UVSQ</orgName>
								<orgName type="institution" key="instit4">CESP</orgName>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="institution">INSERM</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Franck</forename><surname>Carbonnel</surname></persName>
							<affiliation key="aff40">
								<orgName type="institution" key="instit1">Université Paris-Saclay</orgName>
								<orgName type="institution" key="instit2">Université Paris-Sud</orgName>
								<orgName type="institution" key="instit3">UVSQ</orgName>
								<orgName type="institution" key="instit4">CESP</orgName>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="institution">INSERM</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff43">
								<orgName type="department">Department of Gastroenterology</orgName>
								<orgName type="institution" key="instit1">Assistance Publique-Hôpitaux de Paris (AP-HP)</orgName>
								<orgName type="institution" key="instit2">University hospitals Paris-Sud</orgName>
								<address>
									<addrLine>Site de Bicêtre</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff44">
								<orgName type="institution">Paris Sud University</orgName>
								<address>
									<settlement>Paris</settlement>
									<region>XI</region>
								</address>
							</affiliation>
							<affiliation key="aff45">
								<orgName type="institution">Le Kremlin Bicêtre</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gianluca</forename><surname>Severi</surname></persName>
							<affiliation key="aff40">
								<orgName type="institution" key="instit1">Université Paris-Saclay</orgName>
								<orgName type="institution" key="instit2">Université Paris-Sud</orgName>
								<orgName type="institution" key="instit3">UVSQ</orgName>
								<orgName type="institution" key="instit4">CESP</orgName>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="institution">INSERM</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="institution">Gustave Roussy</orgName>
								<address>
									<postCode>F-94805</postCode>
									<settlement>Villejuif</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff46">
								<orgName type="institution">Human Genetics Foundation (HuGeF)</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff47">
								<orgName type="institution">Cancer Council Victoria and University of Melbourne</orgName>
								<address>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catalina</forename><surname>Bonet</surname></persName>
							<affiliation key="aff48">
								<orgName type="department">Cancer Epidemiology Research Programme</orgName>
								<orgName type="laboratory">Unit of Nutrition and Cancer</orgName>
								<orgName type="institution">Catalan Institute of Oncology (ICO)</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Domenico</forename><surname>Palli</surname></persName>
							<affiliation key="aff49">
								<orgName type="institution">Cancer Research and Prevention Institute (ISPO) Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Janke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Molecular Epidemiology Research Group</orgName>
								<orgName type="department" key="dep2">Max Delbrück Center for Molecular Medicine (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Young-Ae</forename><surname>Lee</surname></persName>
							<affiliation key="aff50">
								<orgName type="department">Max Delbrück Center for Molecular Medicine (MDC)</orgName>
								<orgName type="laboratory">Genetics of Allergic Disease Research Group</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heiner</forename><surname>Boeing</surname></persName>
							<affiliation key="aff51">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">German Institute of Human Nutrition (DIfE)</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Edward</forename><forename type="middle">L</forename><surname>Giovannucci</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shuji</forename><surname>Ogino</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff52">
								<orgName type="department" key="dep1">Department of Medical Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute and Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff53">
								<orgName type="department" key="dep1">Division of MPE Molecular Pathological Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Pathology</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charles</forename><forename type="middle">S</forename><surname>Fuchs</surname></persName>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff52">
								<orgName type="department" key="dep1">Department of Medical Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute and Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><surname>Rimm</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kana</forename><surname>Wu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">T</forename><surname>Chan</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Gastroenterology</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Clinical and Translational Epidemiology Unit</orgName>
								<orgName type="institution" key="instit1">Massachusetts General Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff54">
								<orgName type="institution">Broad Institute</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<region>Massachusetts</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Pischon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Molecular Epidemiology Research Group</orgName>
								<orgName type="department" key="dep2">Max Delbrück Center for Molecular Medicine (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff55">
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Max Delbrück Center for Molecular Medicine (MDC)</orgName>
								<orgName type="laboratory">Molecular Epidemiology Research Group</orgName>
								<address>
									<addrLine>Robert-Rössle-Straße 10</addrLine>
									<postCode>13125</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Epidemiology and Biostatistics</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer -a Mendelian Randomization analysis using data from three large cohort studies</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-05-26">2018 May 26.</date>
						</imprint>
					</monogr>
					<idno type="MD5">3DB1E679D23EF44C5A123572D91CC239</idno>
					<idno type="DOI">10.1007/s10654-017-0262-y</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>adiponectin</term>
					<term>ADIPOQ</term>
					<term>colorectal cancer</term>
					<term>Mendelian Randomization</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Higher levels of circulating adiponectin have been related to lower risk of colorectal cancer in several prospective cohort studies, but it remains unclear whether this association may be causal.</s><s>We aimed to improve causal inference in a Mendelian Randomization meta-analysis using nested Nimptsch et al.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Obesity, in particular abdominal obesity is an established risk factor for the development of colorectal cancer <ref type="bibr" target="#b0">(1)</ref>.</s><s>Although the underlying biological mechanisms have not been fully elucidated, it is widely accepted that the adipose tissue, particularly visceral adipose tissue, is an active endocrine organ secreting various bioactive substances collectively named adipokines, which may provide an important link between body fatness and colorectal cancer risk <ref type="bibr" target="#b1">(2)</ref>.</s><s>In contrast to many other adipokines, adiponectin expression is suppressed in obesity and plasma concentrations are lower in obese than in lean individuals (3).</s><s>Adiponectin has been suggested to play a protective role in the development of cancer either directly through inhibition of cell growth (e.g. via RAS signaling (4)) and induction of apoptosis, or indirectly through improved insulin sensitivity and reduced inflammation <ref type="bibr" target="#b4">(5)</ref>.</s><s>The association between circulating adiponectin concentrations and risk of colorectal cancer has been investigated in several prospective cohort studies, with mixed findings: Higher plasma adiponectin concentrations were associated with lower risk of colorectal cancer (slightly stronger in women than men, but no statistically significant sex-differences) in the European Prospective Investigation into Cancer and Nutrition (EPIC) <ref type="bibr" target="#b5">(6)</ref> and in the Health Professionals Follow-up study (HPFS), while no association was observed in the Nurses' Health Study (NHS) <ref type="bibr" target="#b6">(7)</ref>.</s><s>A meta-analysis of ten case-control or nested case-control studies (not including the data from EPIC, NHS or HPFS) reported a statistically significant two percent lower risk of colorectal cancer or adenoma for a 1 μg/mL increment in adiponectin in men whereas among women no association was observed <ref type="bibr" target="#b7">(8)</ref>.</s></p><p><s>To date, it remains unclear whether adiponectin plays a causal role in the development of colorectal cancer not least because it cannot be excluded that residual confounding and/or reverse causation bias might have introduced bias in observational associations (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Mendelian Randomization is a statistical approach that can improve causal inference <ref type="bibr" target="#b8">(9)</ref>.</s><s>The principle is that under the assumption of the random assortment of alleles at conception, genetic variants that are associated with biomarker levels can be used as relatively unbiased proxies for biomarker concentrations due to two advantages.</s><s>First, since the genotype of an individual is determined at gamete formation and cannot be altered later on (e.g. by disease onset), there is no possibility of reverse causation <ref type="bibr" target="#b9">(10)</ref>.</s><s>Second, the relationship between genetic variants and disease risk can be assumed to be not confounded by lifestyle and behavioral factors that can confound the observed association between circulating biomarkers and risk of disease.</s><s>Therefore, using genetic variants associated with circulating biomarker concentrations in a Mendelian Randomization approach may provide insight into the underlying causal relationships by circumventing reverse causation and residual confounding.</s><s>In a pooled analysis from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), which includes data from NHS, HPFS and eight other studies comprising overall more than 7,000 colorectal cancer cases and approximately the same number of controls, genetic variants in the gene encoding adiponectin (ADIPOQ) were not associated with colorectal cancer risk <ref type="bibr" target="#b10">(11)</ref>.</s><s>However, a simultaneous analysis of adiponectin concentrations, ADIPOQ genetic variants and colorectal cancer was not conducted, because adiponectin plasma levels were only available in a subset of included studies, namely NHS and HPFS.</s><s>With a dataset including individual participant data on genetic variants, biomarker concentration and disease outcome, a traditional Mendelian Randomization analysis taking into account the actual strength of the association between ADIPOQ-SNPs and adiponectin concentrations in the study population can be performed, which has the advantage that instrumental variable assumptions can be directly assessed <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b12">13)</ref>.</s><s>The aim of our investigation was therefore to improve causal inference in the association between circulating adiponectin and colorectal cancer risk using ADIPOQ genetic variants in a Mendelian Randomization meta-analysis with individual participant data from the EPIC, HPFS and NHS cohorts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>The three studies included in the present investigation were all nested case-control studies of large prospective cohorts with long follow-up.</s><s>In all nested case-control studies, colorectal cancer was defined according to the International Statistical Classification of Diseases, Injury and Causes of Death (ICD-10) as cancers of the colon (C18.0-C18.7),</s><s>cancers of the rectum (C19-C20) and tumors that were overlapping or unspecified (C18.8-C18.9).</s><s>Blood samples were collected prior to diagnosis and matched control participants were selected using incidence density sampling, i.e. selection was performed among study participants who were alive and free of cancer (except non-melanoma skin cancer) at the time of diagnosis of the colorectal cancer case.</s></p><p><s>The EPIC study is a large multicenter prospective cohort including more than 520,000 study participants from 10 European countries who were aged between 35 and 70 years at recruitment which took place from 1992 to 2000 <ref type="bibr" target="#b13">(14)</ref>.</s><s>Baseline examinations included anthropometric measurements, standardized ascertainment of lifestyle characteristics and medical history information as well as collection of blood samples.</s><s>The EPIC study was approved by the ethical review board of the International Agency for Research on Cancer (IARC, Lyon, France) and the institutional review boards of each participating study center and informed consent was obtained from all participants.</s><s>Incident cancer cases including colorectal cancer cases were determined through record linkage with local cancer registries in most countries (Denmark, Italy (except Naples), the Netherlands, Norway, Spain, Sweden, United Kingdom, complete up to 2003).</s><s>In some countries (France, Germany, Italy (Naples), Greece, complete up to 2002) active follow-up was organized by contact of participants or next of kin through mailed questionnaires, followed by verification of selfreported cases by study physicians using health insurance data, data from cancer and clinical registries as well as medical records provided by the treating physicians.</s><s>In the present analysis, colorectal cancer cases with available prediagnostic blood samples and DNA were included.</s><s>As has been described previously <ref type="bibr" target="#b5">(6)</ref>, the nested case-control design matched each case to one control using incidence density sampling.</s><s>Control participants were selected matched on age at blood collection (2 months to 4-year intervals), study center, fasting status (&lt;3, 3-6, or&gt;6 hours) as well as menopausal status and hormone use in women.</s><s>The nested case-control study was designed to be applicable for several biomarker studies, which explains inclusion of the latter matching criteria which were not relevant for the present analysis.</s><s>The number of cases and matched controls included in the present study is 1,246 (623 cases, 623 matched controls) which is 52% of the study size of the previous analysis on circulating adiponectin and risk of colorectal cancer in EPIC (1,206 cases, 1,206 matched controls) <ref type="bibr" target="#b5">(6)</ref>.</s><s>This difference is largely explained by unavailability of DNA samples from the Danish EPIC centers due to local technical and organizational issues.</s></p><p><s>The HPFS and NHS are two large US cohort studies, detailed descriptions of which are provided elsewhere <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>.</s><s>In brief, the HPFS started in 1986, including 51,529 men aged 40-75 years, and the NHS started in 1976 and included 121,701 women aged 30-55 years.</s><s>In both cohorts, study participants provided information on medical history and lifestyle at recruitment.</s><s>Since then, follow-up questionnaires were administered biennially to collect and update medical and lifestyle information and to elicit medical diagnoses.</s><s>The follow-up rates in both cohorts exceeded 90% in each 2-year cycle and the cumulative follow-up rate (percentage of potentially collected person-years) was 94% in HPFS and 93% in NHS.</s><s>Blood specimens were provided by 18,225 HPFS participants (35%) between 1993 and 1995 and by 32,826 NHS participants (27%) between 1989 and 1990 by overnight courier.</s><s>Details on the procedures of blood collection as well as handling and storage of blood samples have been described previously <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s>Among the participants for whom blood samples and DNA were available, 231 colorectal cancer cases were confirmed after blood collection in HPFS (up to January 1 st 2008) and 399 in NHS (up to October 1 st 2008).</s><s>For each case up to two controls were randomly selected using incidence density sampling.</s><s>The majority of individuals included in the nested case-control studies were of Caucasian ancestry in both HPFS (95.5%) and NHS (99.9%).</s><s>All study participants provided informed consent and the study protocol was approved by the Institutional Review Board of the Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health.</s><s>The total number of participants in the present investigation is 2,880 (1,253 cases and 1,627 controls), including 1,246 in EPIC (623 cases and 623 controls), 461 in HPFS (231 cases, 230 controls) and 1,173 in NHS (399 cases, 774 controls).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Adiponectin measurement</head><p><s>Total circulating adiponectin concentration was measured using enzyme-linked immunosorbent assays from ALPCO Diagnostics (Salem, New Hampshire) in the three studies <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>.</s><s>Based on quality control samples, interbatch coefficients of variation were 8.3% in EPIC and 8.6% in HPFS and NHS.</s><s>Adiponectin measurements in n=300 paired samples from HPFS showed high reliability, with intraclass correlation coefficient of 0.85 when measured within the same persons one year apart <ref type="bibr" target="#b18">(19)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SNP selection and genotyping</head><p><s>In EPIC, a set of tagging SNPs covering variations in the ADIPOQ gene in populations of European ancestry was selected using HapMap 22/phase II CEPH population data (Utah residents with northern and western European descent) applying stringent criteria (minor allele frequency &gt;5% and pairwise r 2 ≥0.8).</s><s>A total number of 15 SNPs were genotyped using TaqMan methodology (genotype call rates &gt;99.2% for all the assays), of which one (rs7649121) was not in Hardy-Weinberg equilibrium in control participants (p&lt;0.0001) and therefore was excluded from analysis.</s><s>In HPFS and NHS SNPs in the ADIPOQ gene were selected based on previous evidence from genome-wide association studies (GWAS) on circulating adiponectin concentrations <ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref>.</s><s>Additional SNPs in adiponectin-related genes that have been associated with colorectal cancer risk were genotyped <ref type="bibr" target="#b23">(24)</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref>.</s><s>A total of 19 SNPs were genotyped using Illumina HumanOmniExpress as part of the GECCO project <ref type="bibr" target="#b10">(11)</ref>.</s><s>Missing SNPs were imputed to HapMap II release 24.</s><s>All genotyped SNPs were in Hardy-Weinberg equilibrium in control participants.</s><s>Eight ADIPOQ SNPs were available in all three included studies (rs1063539, rs16861194, rs822394, rs17300539, rs17366568, rs17366743, rs266729, rs1501299) and minor allele frequencies were comparable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>We created an ADIPOQ allele score which was used to derive Mendelian Randomization estimates in two different approaches: Firstly, we analyzed the ADIPOQ allele score in relation to colorectal cancer risk.</s><s>Secondly, we applied an instrumental variable approach, simultaneously incorporating the ADIPOQ allele score and plasma adiponectin concentrations, to model the association between genetically determined circulating adiponectin and colorectal cancer risk.</s><s>While the first approach, which is considered as an equivalent to the intention-to-treat analysis in a randomized controlled trial <ref type="bibr" target="#b26">(27)</ref>, can only test for the existence of a causal association, the second approach aims at estimating the magnitude of a causal association (e.g.</s><s>risk estimate per 2-fold higher genetically determined adiponectin) <ref type="bibr" target="#b27">(28)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ADIPOQ allele score</head><p><s>The weighted ADIPOQ allele score was constructed by summing alleles that have been associated with higher adiponectin with genome-wide significance in a previous metaanalysis of GWAS on adiponectin levels, using their GWAS-coefficients as weights <ref type="bibr" target="#b19">(20)</ref>.</s><s>Only SNPs not highly correlated (r 2 &lt;0.8) were included in the score.</s><s>For NHS and HPFS, the included SNPs were rs17300539, rs17366568, rs266729, rs1501299 and rs6810075.</s><s>The score in EPIC was built using the same SNPs, except that for rs6810075 the proxy SNP rs182052 was used.</s><s>To examine whether the ADIPOQ allele score is independent of potentially confounding factors, we compared baseline characteristics in each study across score categories (approximate tertiles).</s></p><p><s>The associations between the individual ADIPOQ SNPs as well as the weighted ADIPOQ allele score and adiponectin concentrations were examined using linear regression models with robust variance in control participants <ref type="bibr" target="#b28">(29)</ref>.</s><s>Adiponectin concentrations were naturally log-transformed (because of skewed distribution) and we calculated the estimated relative change in percent in adiponectin per minor allele (with genotypes coded 0, 1 or 2 according to the number of variant alleles) or per score unit, respectively.</s><s>In addition, R 2 and F-values as measures of instrument strength are presented.</s><s>In the previous publication by Song et al. <ref type="bibr" target="#b10">(11)</ref> the association between ADIPOQ SNPs and plasma adiponectin concentrations was presented for HPFS and NHS, but the here included colorectal cancer controls were only a small subset of the individuals included in that analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association between ADIPOQ allele score and colorectal cancer</head><p><s>The association between the ADIPOQ allele score (per score-unit) in relation to risk of colorectal cancer was calculated in each study.</s><s>In EPIC, we used conditional logistic regression conditioning on the matching variables and calculating odds ratios (ORs) and 95% confidence intervals that approximate incidence rate ratios and can be interpreted as relative risks.</s><s>In HPFS and NHS, we used unconditional logistic regression adjusted for matching variables (age at blood draw and date of blood draw) to estimate relative risks.</s><s>In sensitivity analyses, we restricted the logistic regression models to individuals with Caucasian ancestry (n=16 excluded in HPFS and n=1 excluded in NHS).</s><s>Because multivariable adjustment is per definition not required in Mendelian Randomization studies, only minimally adjusted (conditional logistic regression conditioned on the matching variables or unconditional logistic regression adjusted for matching factors) estimates are presented.</s><s>We pooled the study-specific results using a meta-analytic approach with random effects <ref type="bibr" target="#b29">(30)</ref>, thereby also assessing potential heterogeneity across studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Instrumental variable analysis</head><p><s>For the joint analysis of adiponectin concentrations, genetic variants of the ADIPOQ gene and colorectal cancer risk, we performed an instrumental variable analysis using two-stage regression.</s><s>In the first stage, adiponectin concentrations were predicted based on the ADIPOQ allele score by means of linear regression.</s><s>In order to avoid potential bias <ref type="bibr" target="#b30">(31)</ref>, the first stage regression was performed only in control participants and genetically determined adiponectin was predicted for the total study population including participants without measured adiponectin.</s><s>In the second stage, a logistic regression of colorectal cancer on the predicted adiponectin concentrations was performed in each study.</s><s>In EPIC, the second stage was a conditional logistic regression appropriate for the matched design, whereas in HPFS and NHS, the second stage was an unconditional logistic regression adjusted for matching factors.</s><s>For HPFS and NHS, we restricted instrumental variable analyses to individuals of Caucasian ancestry in sensitivity analyses.</s><s>The risk estimates resulting from the instrumental variable analysis display the association between 2-fold genetically determined higher adiponectin in relation to risk of colorectal cancer.</s><s>Pooled associations were determined using random effects model and potential heterogeneity was assessed.</s><s>We performed overidentification tests to evaluate whether the Mendelian Randomization estimates are of similar magnitude across the multiple genetic instruments (i.e.</s><s>individual SNPs included in the ADIPOQ allele score) <ref type="bibr" target="#b27">(28)</ref>.</s><s>Finally, to increase statistical power, we performed a summary instrumental variable analysis using published data on genetic associations with adiponectin and colorectal cancer in a likelihood-based approach <ref type="bibr" target="#b12">(13)</ref>.</s><s>Parameters for the association between the SNPs included in the ADIPOQ allele score and circulating adiponectin were taken from GWAS data <ref type="bibr" target="#b19">(20)</ref> and parameters for the association between the SNPs and colorectal cancer were derived from the analysis in GECCO <ref type="bibr" target="#b10">(11)</ref>.</s><s>Because summary instrumental variable analysis can be biased when correlated SNPs are included <ref type="bibr" target="#b12">(13)</ref>, we omitted rs266729 from this analysis, because it is in linkage disequilibrium with rs6810075 (r 2 =0.5).</s></p><p><s>All statistical tests are two-sided with significance at the 5% level.</s><s>Instrumental variable analyses were performed using the STATA SE 12 (StataCorp, College Station, Texas, USA).</s><s>Summary instrumental variable analyses were performed with a publicly available R-Studio application (Foundation for Statistical Computing, Vienna, Austria).</s><s>All other analyses were performed using SAS (for EPIC data: SAS Enterprise Guide 4.3; for HPFS and NHS data: SAS 9.3; SAS Institute Inc., Cary, North Carolina, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Baseline characteristics of study participants in EPIC, HPFS and NHS are displayed in Table <ref type="table">1</ref>.</s><s>In EPIC and HPFS, incident colorectal cancer cases had statistically significantly higher body mass index (BMI) and waist circumference than controls at baseline, whereas in NHS, these anthropometric measures did not differ between case and control participants.</s><s>In EPIC, colorectal cancer cases consumed more alcohol and red and processed meat than control participants, whereas in the US cohorts, no such differences were observed.</s><s>Other potentially confounding factors including physical activity and fiber intake did not differ remarkably between cases and controls in any study.</s><s>In EPIC and HPFS, but not in NHS, adiponectin concentrations were lower in cases than in control participants in univariate comparisons.</s></p><p><s>Of the 14 ADIPOQ SNPs available for analysis in EPIC, five SNPs were statistically significantly associated with circulating adiponectin (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Each unit of the GWASbased ADIPOQ allele score was associated with 6.5 % (95% CI 3.6, 9.4) higher adiponectin.</s><s>The ADIPOQ allele score explained 3.2% of the interindividual variation in adiponectin concentrations (F-value 20.2).</s><s>In HPFS, three of the 19 genotyped SNPs were statistically significantly associated with adiponectin concentrations (Table <ref type="table" target="#tab_2">3</ref>).</s><s>Each unit of the ADIPOQ allele score was associated with 7.7 % (95% CI 0.9, 14.9) higher adiponectin (F-value 5.0).</s><s>In NHS, six of the 19 available SNPs were statistically significantly associated with circulating adiponectin.</s><s>The ADIPOQ allele score was associated with 7.7 % (95% CI 4.1, 11.3) higher adiponectin concentrations and explained 3.6% of the interindividual variation in circulating adiponectin (F-value 18.8).</s></p><p><s>Potentially confounding factors assessed in the three cohorts did not differ remarkably across categories (approximate tertiles) of the ADIPOQ allele score (all P-values &gt;0.05, supplemental table 1).</s></p><p><s>The ADIPOQ allele score was not statistically significantly associated with risk of colorectal cancer (pooled OR per score-unit 0.97, 95% CI 0.91, 1.04) in logistic regression analysis (table <ref type="table" target="#tab_3">4</ref>).</s><s>This result was not altered when logistic regression analyses were restricted to Caucasian individuals in HPFS and NHS (pooled OR 0.97, 95% CI 0.91, 1.04).</s><s>In the instrumental variable analysis taking measured adiponectin and ADIPOQ genetic variation in our study population simultaneously into account (table <ref type="table" target="#tab_4">5</ref>), using the ADIPOQ allele score as instrumental variable, genetically determined two-fold higher adiponectin was not statistically significantly associated with lower risk of colorectal cancer (pooled OR 0.73, 95% CI 0.40, 1.34).</s><s>These associations were not altered by restriction to Caucasians in HPFS and NHS (pooled OR 0.73, 95% CI 0.41, 1.33).</s><s>Over-identification tests suggested that the Mendelian Randomization estimates for colorectal cancer risk were similar across the individual SNPs included in the ADIPOQ allele score (P-values testing the nullhypothesis of identical effects across instruments were 0.64 in EPIC, 0.81 in HPFS and 0.52 in NHS).</s></p><p><s>In the summary instrumental variable analysis using published data, no association between genetically determined higher adiponectin and risk of colorectal cancer was observed (OR per 2-fold higher adiponectin 0.99, 95% CI 0.93, 1.06 in women and 0.94, 95% CI 0.88, 1.01 in men) using the four SNPs rs1730539, rs17366568, rs1501299 and rs6810075 as instrumental variables.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this Mendelian Randomization analysis using data from three nested case-control studies of large prospective cohorts, we did not find evidence for a causal contribution of high adiponectin levels to lower risk of colorectal cancer.</s><s>However, adiponectin concentrations were genetically determined only to a limited extent, which limited statistical power for our Mendelian Randomization analysis.</s></p><p><s>In a genetic association meta-analysis, the minor alleles of three ADIPOQ SNPs (rs1501299, rs2241766, rs266729) were associated with colorectal cancer risk <ref type="bibr" target="#b31">(32)</ref>, but associations were only seen in Asians and not in Caucasians.</s><s>Individual SNPs at the ADIPOQ loci (rs17300539, rs17366568, rs17366743, rs1501299, rs3774261 (the proxy SNPs rs2241766 was used in GECCO), rs6810075, rs266729, rs6773957, rs6444175, rs1063538), including those incorporated in the ADIPOQ allele score in the present study, were unrelated to risk of colorectal cancer in GECCO <ref type="bibr" target="#b10">(11)</ref>.</s><s>In the same study, the allele-sum of 16 SNPs that have been related to higher adiponectin concentrations in previous GWAS were combined in a genetic score, which was not related to colorectal cancer risk in women (OR per ten-allele increment 1.08, 95% CI 0.95, 1.22) or men (OR 1.01, 95% CI 0.90, 1.13).</s><s>In contrast, in a two-sample Mendelian Randomization meta-analysis (33) using the ADIPOQ SNP rs2241766 as instrumental variable, 1 mg/L genetically determined higher adiponectin was associated with a 20-40% higher risk of colorectal cancer.</s></p><p><s>The strength of our study is the ability to jointly investigate adiponectin, genetic variation in the ADIPOQ gene and risk of colorectal cancer.</s><s>In contrast to a two-sample Mendelian Randomization design, a full sample design, where genetic information and intermediate phenotype data (i.e.</s><s>measured adiponectin concentration) are available in the same study participants, generally requires less assumptions and allows for systematic evaluation of instrumental variable assumptions <ref type="bibr" target="#b33">(34)</ref>.</s><s>Thus, we were able to estimate the strength of the association between the ADIPOQ SNPs as well as the ADIPOQ allele score and adiponectin concentrations in our sample, thereby showing that the first Mendelian Randomization assumption was fulfilled.</s><s>Furthermore, we showed that potentially confounding lifestyle factors did not vary substantially across categories of the instrumental variable, i.e. the second Mendelian Randomization assumption was also satisfied <ref type="bibr" target="#b34">(35)</ref>.</s><s>It should be noted that only potentially confounding factors measured in the three studies could be investigated, thus, it cannot be entirely excluded that unmeasured confounders varied by categories of the ADIPOQ allele score.</s><s>Assessment of the third Mendelian Randomization assumption (instrumental variable is associated with the outcome only through the intermediate exposure of interest, i.e. no pleiotropy) is not as straightforward, but the use of multiple SNPs as instrumental variables argues against unknown pleiotropy if the Mendelian Randomization estimates are similar across the multiple independent instruments, which was confirmed in our samples by the non-significant over-identification test results.</s><s>Furthermore, the genetic variants used as instrumental variables were restricted to the ADIPOQ gene and therefore likely act directly on the adiponectin trait, which argues also against pleiotropic effects <ref type="bibr" target="#b26">(27)</ref>.</s></p><p><s>However, our study has also several limitations: Given the limited genetic determination of adiponectin concentrations, our sample sizes from three nested case-control studies of prospective cohorts was limited to derive robust causal estimates.</s><s>The ADIPOQ allele score applied here explained only a low proportion (2.9%-3.6%) of the interindividual variation in adiponectin concentrations.</s><s>With this genetic instrument and our sample size, the minimal OR that could have been detected with 80% statistical power was 0.61 per standard deviation in adiponectin, which is a stronger association than has been observed in most observational studies <ref type="bibr" target="#b7">(8)</ref>.</s><s>Even with the relatively large sample size in GECCO (7,020 cases, 7,631 controls) no association between a genetic score of variants associated with adiponectin and colorectal cancer was detected <ref type="bibr" target="#b10">(11)</ref>.</s><s>Furthermore, in our summary data instrumental variable analysis, genetically determined higher adiponectin was not associated with colorectal cancer risk (minimal detectable OR with 80% power: 0.76 per standard deviation in adiponectin).</s><s>A much larger sample size (n=33,960 cases, 33,960 controls) would be necessary to detect a moderate effect (e.g.</s><s>OR 0.89 per 1 SD as observed in EPIC ( <ref type="formula">6</ref>)) of adiponectin and colorectal cancer.</s><s>Therefore, with our study and the summary instrumental variable analysis based on GECCO, we cannot rule out causality in the association between circulating adiponectin and risk of colorectal cancer.</s><s>Although it has been suggested that the 2-stage instrumental variable estimator may result in biased estimates under case-control sampling, it has been shown to be unbiased under the null hypothesis of no causal effect as in the present study <ref type="bibr" target="#b35">(36)</ref>.</s></p><p><s>In conclusion, this Mendelian Randomization meta-analysis using individual data from three nested case-control studies of prospective cohorts does not support a causal effect of circulating adiponectin on colorectal cancer risk.</s><s>This lack of association may be related to the limited genetic determination of adiponectin and the limited sample size.</s><s>Therefore, larger Mendelian Randomization studies are necessary to clarify whether adiponectin is causally related to lower risk of colorectal cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s><s>Association between ADIPOQ SNPs genotyped in EPIC, ADIPOQ allele score and plasma adiponectin levels in control participants  Association between all ADIPOQ SNPs genotyped in HPFS and NHS, ADIPOQ allele score and plasma adiponectin levels in control participants</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Directed acyclic graph (DAG) for Mendelian Randomization Study on adiponectin and colorectal cancer risk.</s><s>X: modifiable exposure of interest; Y: outcome; C: confounder(s); Z: instrumental variable.</s><s>NOTE: The effect of Z on Y should be mediated only through X (no pleiotropy), therefore this line is dashed.</s><s>Associations [ZX] and [ZY] are used to estimate the causal effect of a biomarker on an outcome circumventing residual confounding and reverse causation.</s></p></div></figDesc><graphic coords="14,191.04,62.00,289.92,119.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Table 1</head><label>1</label><figDesc><div><p><s>Baseline characteristics of study participants in EPIC, HPFS and NHS at blood collection, years, mean (SD) 58.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>allele frequency; 95% CI, 95% confidence interval a Percent change in adiponectin concentrations per copy of minor allele (effect allele) or score unit, estimated in univariable linear regression models.</s><s>b incorporated in ADIPOQ allele score for EPIC c proxy SNP for rs6810075 in bold: statistically significant associations (p&lt;0.05)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>allele frequency; 95% CI, 95% confidence interval a Percent change in adiponectin concentrations per copy of minor allele (effect allele) or score unit, estimated in univariable linear regression models.</s><s>b incorporated in ADIPOQ allele score for HPFS/NHS in bold: statistically significant associations (p&lt;0.05)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>Adiponectin measurement was not available in n=16 controls and n=7 cases in EPIC, in n=63 controls and n=56 cases in HPFS, and in n=264 controls and n=112 cases in NHS; some study participants had missing values for the here displayed diet and lifestyle factors: in EPIC, there were missing values on physical activity (n=69 controls, n=67 cases) and waist circumference (n=65 controls, n=65 cases); in HPFS, there were missing values on smoking status (n=7 controls, n=6 cases), waist circumference (n=25 controls, n=46 cases), alcohol (n=4 controls, n=5 cases), fiber (n=1 case) or red and processed meat (n=4 controls, n=5 cases) intake; in NHS, there were missing values on alcohol (n=8 controls, n=1 cases), fiber (n=11 controls, n=2 cases) and red and processed meat (n=8 controls, n=1 case) intake.</s><s>b P-values for the difference between cases and controls were determined by Mc Nemar's test for variables expressed as %, by student's paired t-test for variables expressed as means, and by Wilcoxon's signed rank test for variables expressed as medians c P-values for the difference between cases and controls were determined by Chi 2 -test for variables expressed as %, analysis of variance (general linear model) for variables expressed as means, and by the non-parametric Kruskal-Wallis test for variables expressed as medians</s></p></div></figDesc><table><row><cell>59.2 (6.7) *</cell><cell>48 (12.1) 0.85</cell><cell>399 (100) 0.47</cell><cell>16.5 (19.2) 0.88</cell><cell></cell><cell>25.3 (4.3) 0.72</cell><cell>80.3 (10.9) 0.41</cell><cell>1.8 (0.0-8.5) 0.07</cell><cell>17.7 (15.2-21.1) 0.34</cell><cell>55.8 (33.4-91.7) 0.23</cell><cell>8.5 (6.0-11.5) 0.64</cell><cell></cell><cell></cell></row><row><cell>59.1 (6.7)</cell><cell>90 (11.7)</cell><cell>773 (99.9)</cell><cell>16.4 (19.8)</cell><cell></cell><cell>25.4 (4.4)</cell><cell>79.5 (10.7)</cell><cell>1.1 (0.0-6.9)</cell><cell>18.1 (15.1-21.3)</cell><cell>52.4 (33.4-81.2)</cell><cell>8.5 (6.0-11.0)</cell><cell></cell><cell></cell></row><row><cell>*</cell><cell>0.35</cell><cell>0.04</cell><cell>0.70</cell><cell></cell><cell>0.004</cell><cell>0.004</cell><cell>0.86</cell><cell>0.34</cell><cell>0.20</cell><cell>0.21</cell><cell></cell><cell></cell></row><row><cell>66.1 (8.8)</cell><cell>8 (3.6)</cell><cell>219 (94.8)</cell><cell>35.8 (41.3)</cell><cell></cell><cell>26.0 (3.1)</cell><cell>96.8 (8.4)</cell><cell>6.9 (0.9-18.7)</cell><cell>22.2 (18.4-27.2)</cell><cell>64.5 (37.5-105.5)</cell><cell>5.3 (3.5-7.2)</cell><cell></cell><cell></cell></row><row><cell>65.6 (8.9)</cell><cell>12 (5.4)</cell><cell>226 (98.3)</cell><cell>34.5 (29.2)</cell><cell></cell><cell>25.2 (3.3)</cell><cell>94.2 (9.4)</cell><cell>7.0 (1.8-15.8)</cell><cell>22.7 (18.6-28.8)</cell><cell>63.4 (33.5-98.1)</cell><cell>5.6 (3.9-8.2)</cell><cell></cell><cell></cell></row><row><cell>*</cell><cell>0.88</cell><cell>n.a.</cell><cell>0.59</cell><cell></cell><cell>0.001</cell><cell>&lt;0.0001</cell><cell>0.02</cell><cell>0.77</cell><cell>0.02</cell><cell>0.01</cell><cell></cell><cell></cell></row><row><cell>3 (8.2) 58.3 (8.2)</cell><cell>Current smoking, n (%) 124 (19.9) 122 (19.6)</cell><cell>Caucasian ethnicity, n (%) n.a. n.a.</cell><cell>Physical activity (MET-hours/week), mean 89.1 (52.1) 90.4 (54.8)</cell><cell>(SD)</cell><cell>Body mass index, kg/m 2 , mean (SD) 26.4 (3.8) 27.1 (4.4)</cell><cell>Waist circumference, cm, mean (SD) 89.3 (12.3) 91.9 (13.1)</cell><cell>Alcohol intake, g/day, median (IQR) 6.4 (1.0-21.1) 7.8 (0.8-22.6)</cell><cell>Fiber, g/day, median (IQR) 21.8 (17.7-27.0) 21.5 (16.8-27.5)</cell><cell>Red and processed meat, g/day, median (IQR) 69.1 (45.4-101.5) 72.3 (49.4-108.8)</cell><cell>Total adiponectin (μg/mL), median (IQR) c 6.3 (4.8-8.7) 5.9 (4.3-8.2)</cell><cell>SD, standard deviation, IQR, inter-quartile range, MET, metabolic equivalent of task</cell><cell>a</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc><div><p><s>Association between ADIPOQ allele score and colorectal cancer risk in EPIC, HPFS, and NHS Conditional logistic regression, controlling for matching factors (age at blood collection, study center, fasting status, menopausal status and hormone use in women) c Unconditional logistic regression, adjusted for matching factors(age at blood draw, date of blood draw) OR, odds ratio; 95% CI, 95% confidence interval; p het. , P value for heterogeneity by study</s></p></div></figDesc><table><row><cell>p het.</cell><cell></cell><cell></cell><cell></cell><cell>0.86</cell><cell></cell><cell></cell></row><row><cell>p trend</cell><cell>0.23</cell><cell>0.97</cell><cell>0.73</cell><cell>0.43</cell><cell></cell><cell></cell></row><row><cell>No. Cases/No. Controls Relative change % a OR (95% CI)</cell><cell>EPIC b 623/623 6.5 0.95 (0.87, 1.03)</cell><cell>HPFS c 231/230 7.7 1.00 (0.85, 1.17)</cell><cell>NHS c 399/774 7.7 0.98 (0.88, 1.09)</cell><cell>Pooled 1253/1627 0.97 (0.91, 1.04)</cell><cell>a Per score unit, estimates based on univariate linear regression in controls</cell><cell>b</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5</head><label>5</label><figDesc><div><p><s>Instrumental variable estimation of the association between genetically determined adiponectin concentrations with risk of colorectal cancer in EPIC, HPFS, and NHS (ADIPOQ allele score as instrumental variable) OR derived from two-stage regression.</s><s>First stage was a linear regression.</s><s>In EPIC, the second stage was a conditional logistic regression controlling for matching factors (age at blood collection, study center, fasting status, menopausal status and hormone use in women); in HPFS and NHS, the second stage was an unconditional logistic regression adjusting for matching factors (age at blood draw, date of blood draw)</s></p></div></figDesc><table><row><cell>No. Cases/No. Controls IV-OR (95% CI) p trend p het.</cell><cell>EPIC 623/623 0.61 (0.25, 1.49) 0.28</cell><cell>HPFS 231/230 0.90 (0.21, 3.84) 0.89</cell><cell>NHS 399/774 0.83 (0.31, 2.22) 0.71</cell><cell>Pooled 1253/1627 0.73 (0.40, 1.34) 0.31 0.86</cell><cell>het. , P value for heterogeneity by study IV-OR, instrumental variable odds ratio; 95% CI, 95% confidence interval; p</cell><cell>IV-</cell></row></table><note><p><s>p het. , P value for heterogeneity by study Eur J Epidemiol.</s><s>Author manuscript; available in PMC 2018 May 26.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Eur J Epidemiol. Author manuscript; available in PMC 2018May 26.   </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer</title>
		<imprint>
			<date type="published" when="2011">2011</date>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">Continuous Update Project Report</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Adipocytokines: mediators linking adipose tissue, inflammation and immunity</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tilg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moschen</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri1937</idno>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Immunology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="772" to="783" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Adiponectin: more than just another fat cell hormone? Diabetes care</title>
		<author>
			<persName><forename type="first">M</forename><surname>Chandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ciaraldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Henry</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2442" to="2450" />
		</imprint>
	</monogr>
	<note>PubMed: 12882876</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status</title>
		<author>
			<persName><forename type="first">K</forename><surname>Inamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djv363</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Adiponectin represses colon cancer cell proliferation via AdipoR1-and -R2-mediated AMPK activation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1210/me.2009-0498</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1441" to="1452" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20444885</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Aleksandrova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Boeing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jenab</surname></persName>
		</author>
		<idno type="DOI">10.1093/carcin/bgs133</idno>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1158/1940-6207.CAPR-13-0169</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer prevention research</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="875" to="885" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">T</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Tong</surname></persName>
		</author>
		<idno>DOI: 10.1111/j. 1751-2980.2011.00504.x</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of digestive diseases</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="234" to="244" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21791018</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Mendelian randomization&apos;: can genetic epidemiology contribute to understanding environmental determinants of disease?</title>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of epidemiology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="22" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12689998</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno>DOI: 10.1007/ s00439-007-0448-6</idno>
	</analytic>
	<monogr>
		<title level="j">Human genetics</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="33" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18038153</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genetic variants of adiponectin and risk of colorectal cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Giovannucci</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.29360</idno>
	</analytic>
	<monogr>
		<title level="j">International journal of cancer</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Pierce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<idno type="DOI">10.1093/aje/kwt084</idno>
	</analytic>
	<monogr>
		<title level="j">American journal of epidemiology</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1177" to="1184" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23863760</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Mendelian randomization analysis with multiple genetic variants using summarized data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Butterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1002/gepi.21758</idno>
	</analytic>
	<monogr>
		<title level="j">Genetic epidemiology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="658" to="665" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24114802</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection</title>
		<author>
			<persName><forename type="first">E</forename><surname>Riboli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Slimani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Public Health Nutr</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6B</biblScope>
			<biblScope unit="page" from="1113" to="1124" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12639222</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Journal of women&apos;s health/the official publication of the Society for the Advancement of Women&apos;s Health Research</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hankinson</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="49" to="62" />
		</imprint>
	</monogr>
	<note>The Nurses&apos; Health Study: 20-year contribution to the understanding of health among women</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prospective study of alcohol consumption and risk of coronary disease in men</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Rimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Giovannucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="issue">8765</biblScope>
			<biblScope unit="page" from="464" to="468" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note>PubMed: 1678444</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giovannucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Mantzoros</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/dji376</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="1688" to="1694" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16288122</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hankinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1297" to="1302" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>PubMed: 7658481</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Adiponectin: stability in plasma over 36 hours and withinperson variation over 1 year</title>
		<author>
			<persName><forename type="first">T</forename><surname>Pischon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hotamisligil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Rimm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical chemistry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="650" to="652" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12651819</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Dastani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Hivert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Timpson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS genetics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">29</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Heid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Henneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hicks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="412" to="420" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20018283</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Waterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Stirnadel</surname></persName>
		</author>
		<idno type="DOI">10.1038/oby.2008.625</idno>
	</analytic>
	<monogr>
		<title level="j">Obesity</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="737" to="744" />
			<date type="published" when="2009">2009</date>
			<publisher>Silver Spring</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A genome-wide association study reveals variants in ARL15 that influence adiponectin levels</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Waterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>O'rahilly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS genetics</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population</title>
		<author>
			<persName><forename type="first">B</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2350-12-94</idno>
	</analytic>
	<monogr>
		<title level="j">BMC medical genetics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">94</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21749709</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Kaklamani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Wisinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadim</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.300.13.1523</idno>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1523" to="1531" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18827209</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer</title>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wei</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0027301</idno>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">e27301</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22087284</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Mendelian randomization: genetic anchors for causal inference in epidemiological studies</title>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hemani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1093/hmg/ddu328</idno>
	</analytic>
	<monogr>
		<title level="j">Human molecular genetics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">R1</biblScope>
			<biblScope unit="page" from="R89" to="98" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25064373</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Haycock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Relton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.3945/ajcn.115.118216</idno>
	</analytic>
	<monogr>
		<title level="j">The American journal of clinical nutrition</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity</title>
		<author>
			<persName><forename type="first">H</forename><surname>White</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Econometrica</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="817" to="838" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Meta-analysis in clinical trials</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dersimonian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Laird</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Control Clin Trials</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="177" to="188" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note>PubMed: 3802833</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">A review of instrumental variable estimators for Mendelian randomization. Statistical methods in medical research</title>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1177/0962280215597579</idno>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">Adiponectin Gene Polymorphisms are Associated with Increased Risk of Colorectal Cancer. Medical science monitor: international medical journal of experimental and clinical research</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cai</surname></persName>
		</author>
		<idno type="DOI">10.12659/MSM.893472</idno>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2595" to="2606" />
		</imprint>
	</monogr>
	<note>PubMed: 26329379</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Niu</surname></persName>
		</author>
		<idno>DOI: 10.1007/ s13277-014-2654-x</idno>
	</analytic>
	<monogr>
		<title level="j">Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="585" to="594" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25273172</note>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annual review of genomics and human genetics</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1146/annurev-genom-090314-050016</idno>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="327" to="350" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Methodological challenges in mendelian randomization</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Vanderweele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Tchetgen Tchetgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cornelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kraft</surname></persName>
		</author>
		<idno>DOI: 10.1097/ EDE.0000000000000081</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="427" to="435" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Mendelian randomization studies for a continuous exposure under case-control sampling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">C</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1093/aje/kwu291</idno>
	</analytic>
	<monogr>
		<title level="j">American journal of epidemiology</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="440" to="449" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25713335</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
